Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Influenza

  Free Subscription


08.07.2024

2 Am J Med
1 Antiviral Res
1 BMC Pediatr
5 BMJ
1 Drug Saf
2 J Exp Med
1 J Infect Dis
1 J Virol
1 JAMA
4 Lancet
2 Pediatrics
19 PLoS One
3 Proc Natl Acad Sci U S A
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med

  1. ZHAI L, Gong H, Yu W
    New Insights on Obstructive Sleep Apnea and Postacute Sequelae of SARS-CoV-2 Infection.
    Am J Med. 2024;137:e139.
    PubMed        

  2. ALAEDINI A, Lightman S, Wormser GP
    Is Low Cortisol a Marker of Long COVID?
    Am J Med. 2024;137:564-565.
    PubMed        


    Antiviral Res

  3. LV L, Yang X, Zhang Y, Ren X, et al
    hnRNPAB inhibits Influenza A virus infection by disturbing polymerase activity.
    Antiviral Res. 2024;228:105925.
    PubMed         Abstract available


    BMC Pediatr

  4. BAUHOFER AFL, Ussivane E, Chissaque A, Iahaia F, et al
    SARS-CoV-2 in Mozambican primary school-aged children at Maputo City and Province: a cross-sectional study from a low-income country.
    BMC Pediatr. 2024;24:425.
    PubMed         Abstract available


    BMJ

  5. DYER O
    Mpox: Virus behind new DRC outbreak is most dangerous strain yet, experts warn.
    BMJ. 2024;385:q1454.
    PubMed        

  6. DOSHI P
    Revolving door: You are free to influence us "behind the scenes," FDA tells staff leaving for industry jobs.
    BMJ. 2024;386:q1418.
    PubMed        

  7. WISE J
    Sixty seconds on . . . hologram doctors.
    BMJ. 2024;386:q1456.
    PubMed        

  8. MIR FA
    We need a royal commission to save the struggling NHS.
    BMJ. 2024;386:q1464.
    PubMed        

  9. FOX K
    We need a contract between the public and the NHS that focuses on prevention.
    BMJ. 2024;386:q1470.
    PubMed        


    Drug Saf

  10. DE LA CUEVA IS, Gerber JE, Hastie A, Brotons C, et al
    Enhanced Safety Surveillance of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season.
    Drug Saf. 2024 Jun 29. doi: 10.1007/s40264-024-01456.
    PubMed         Abstract available


    J Exp Med

  11. ZANONI I
    Kids' noses resist COVID-19.
    J Exp Med. 2024;221:e20241027.
    PubMed         Abstract available

  12. WATKINS TA, Green AB, Amat JAR, Cheemarla NR, et al
    High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children.
    J Exp Med. 2024;221:e20230911.
    PubMed         Abstract available


    J Infect Dis

  13. MCCARRON M, Yau TS, Griffin C, Marcenac P, et al
    Do pregnant persons want influenza vaccines? Knowledge, attitudes, perceptions, and practices toward influenza vaccines in 8 low- and middle-income countries.
    J Infect Dis. 2024 Jul 2:jiae340. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  14. SPACKMAN E, Jones DR, McCoig AM, Colonius TJ, et al
    Characterization of highly pathogenic avian influenza virus in retail dairy products in the US.
    J Virol. 2024 Jul 3:e0088124. doi: 10.1128/jvi.00881.
    PubMed         Abstract available


    JAMA

  15. FANG Z, Ahrnsbrak R, Rekito A
    Evidence Mounts That About 7% of US Adults Have Had Long COVID.
    JAMA. 2024;332:5-6.
    PubMed        


    Lancet

  16. GARCIA PJ, Saavedra J, Espinoza-Pajuelo L, Garcia-Terron FA, et al
    Why Latin America needs a regional Centre for Disease Control and Prevention.
    Lancet. 2024;403:2763-2765.
    PubMed        

  17. THE LANCET
    UK elections: the need for a healthy change.
    Lancet. 2024;403:2755.
    PubMed        

  18. DIEDRICH L
    Illness politics and social media mobilisation.
    Lancet. 2024;403:2776-2777.
    PubMed        

  19. SAMARASEKERA U
    No parties meeting the challenge on health in the UK.
    Lancet. 2024;403:2769-2770.
    PubMed        


    Pediatrics

  20. MICHELSON KA, Ramgopal S, Kociolek LK, Zerr DM, et al
    Children's Hospital Resource Utilization During the 2022 Viral Respiratory Surge.
    Pediatrics. 2024;154:e2024065974.
    PubMed         Abstract available

  21. MCMORROW ML, Moline HL, Toepfer AP, Halasa NB, et al
    Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016-2022.
    Pediatrics. 2024;154:e2023065623.
    PubMed         Abstract available


    PLoS One

  22. WANG Z, Zhu Y, Wang T, Su T, et al
    Innovative behavior and organizational innovation climate among the Chinese clinical first-line nurses during the Omicron pandemic: The mediating roles of self-transcendence.
    PLoS One. 2024;19:e0306109.
    PubMed         Abstract available

  23. RAJI T, Fallah MP, Dereje N, Kakooza F, et al
    Efficacy and effectiveness of COVID-19 vaccines in Africa: A systematic review.
    PLoS One. 2024;19:e0306309.
    PubMed         Abstract available

  24. KABIR MF, Nyein Yin K, Htwe O, Saffree Jeffree M, et al
    Symptom response and episodic disability of long COVID in people with spinal cord injury: A case-control study.
    PLoS One. 2024;19:e0304824.
    PubMed         Abstract available

  25. HUMPHREYS H, Baxter R, Gilroy J, Cavalleri GL, et al
    All hands on deck during the COVID-19 pandemic. Maintaining face-to-face medical education and clinical placements.
    PLoS One. 2024;19:e0306129.
    PubMed         Abstract available

  26. FRASNELLI J, Tognetti A, Winter AL, Thunell E, et al
    High prevalence of long-term olfactory disorders in healthcare workers after COVID-19: A case-control study.
    PLoS One. 2024;19:e0306290.
    PubMed         Abstract available

  27. SHANLEY A, O'Donnell K, Weatherburn P, Gilmore J, et al
    Understanding sexual health service access for gay, bisexual and other men who have sex with men in Ireland during the COVID-19 crisis: Findings from the EMERGE survey.
    PLoS One. 2024;19:e0306280.
    PubMed         Abstract available

  28. MUKANTWALI MB, Niyonsenga J, Uwingeneye L, Kanyamanza CU, et al
    Prevalence of depression, anxiety and stress and their risk and protective factors among secondary students in Rwanda during the first wave of COVID-19 pandemic.
    PLoS One. 2024;19:e0306389.
    PubMed         Abstract available

  29. DOYLE AJ, Murphy CC, Boland F, Pawlikowska T, et al
    Education in focus: Significant improvements in student learning and satisfaction with ophthalmology teaching delivered using a blended learning approach.
    PLoS One. 2024;19:e0305755.
    PubMed         Abstract available

  30. KIM YR, Min Y, Okogun-Odompley JN
    A mathematical model of COVID-19 with multiple variants of the virus under optimal control in Ghana.
    PLoS One. 2024;19:e0303791.
    PubMed         Abstract available

  31. MALAMBO W, Chanda D, Besa L, Engamba D, et al
    Clinical characteristics and factors associated with long COVID among post-acute COVID-19 clinic patients in Zambia, August 2020 to January 2023: A cross-sectional and longitudinal study design.
    PLoS One. 2024;19:e0306131.
    PubMed         Abstract available

  32. BUTZMANN J, Hellriegel-Nehrkorn A, Dilas M, Pohl R, et al
    Determining the optimal frequency of SARS-CoV-2 regular asymptomatic testing: A randomized feasibility trial in a home care setting.
    PLoS One. 2024;19:e0303344.
    PubMed         Abstract available

  33. SCOGLIO AAJ, Stelson EA, Becene I, Marquez CI, et al
    A mixed-methods analysis of moral injury among healthcare workers during the COVID-19 pandemic.
    PLoS One. 2024;19:e0304620.
    PubMed         Abstract available

  34. HU X
    Multiliteracies meet new methods: The case for digital writing in English education case study in G-7 countries.
    PLoS One. 2024;19:e0304343.
    PubMed         Abstract available

  35. SMITH DG, Smith CD, DeLeon JA, Sandoz JL, et al
    Factors influencing COVID-19 vaccine uptake among Latinos: A cross-sectional study.
    PLoS One. 2024;19:e0302332.
    PubMed         Abstract available

  36. WEI F, Zhou R, Jin Z, Sun Y, et al
    Studying the impacts of variant evolution for a generalized age-group transmission model.
    PLoS One. 2024;19:e0306554.
    PubMed         Abstract available

  37. YAZDANI Y, Pai P, Sayfi S, Mohammadi A, et al
    Predictors of COVID-19 vaccine acceptability among refugees and other migrant populations: A systematic scoping review.
    PLoS One. 2024;19:e0292143.
    PubMed         Abstract available

  38. XIA Z, Chen J, Sun A
    Mining the relationship between COVID-19 sentiment and market performance.
    PLoS One. 2024;19:e0306520.
    PubMed         Abstract available

  39. ORTIZ RIOFRIO AG, Valdivieso-Andrade EJ, Acosta Masaquiza NM, Aguirre AS, et al
    COVID-19: Medical education from the point of view of medical students using the participatory Delphi method.
    PLoS One. 2024;19:e0297602.
    PubMed         Abstract available

  40. RIZAL MF, Hafidz F, Kusila GR, Aisyiah W, et al
    Hospital services utilisation and cost before and after COVID-19 hospital treatment: Evidence from Indonesia.
    PLoS One. 2024;19:e0305835.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  41. DE LA PRADA AG, Small ML
    How people are exposed to neighborhoods racially different from their own.
    Proc Natl Acad Sci U S A. 2024;121:e2401661121.
    PubMed         Abstract available

  42. PURCELL H, Kohler IV, Ciancio A, Mwera J, et al
    Mortality risk information and health-seeking behavior during an epidemic.
    Proc Natl Acad Sci U S A. 2024;121:e2315677121.
    PubMed         Abstract available

  43. WU Q, Rafatian N, Wagner KT, Blamer J, et al
    SARS-CoV-2 pathogenesis in an angiotensin II-induced heart-on-a-chip disease model and extracellular vesicle screening.
    Proc Natl Acad Sci U S A. 2024;121:e2403581121.
    PubMed         Abstract available


    Virology

  44. ZHU H, Li X, Li X, Chen H, et al
    Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide.
    Virology. 2024;597:110162.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.